Assignment of Orphan Drug Designation. Except to the extent prohibited by the Biologics Regulatory Scheme, Diacrin hereby assigns and Diacrin and Genzyme hereby agree to assign to Diacrin/Genzyme LLC any "Orphan Drug" designations for any Collaboration Products which Diacrin has received or Diacrin or Genzyme may receive during the term of this Agreement.
Appears in 2 contracts
Sources: Collaboration Agreement (Diacrin Inc /De/), Collaboration Agreement (Diacrin Inc /De/)